Terbequinil
Clinical data | |
---|---|
ATC code | none |
Identifiers | |
| |
CAS Number | 113079-82-6 |
PubChem (CID) | 65916 |
ChemSpider | 59325 |
UNII | 0DH9WUS03O |
Chemical and physical data | |
Formula | C15H18N2O3 |
Molar mass | 274.315 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
Terbequinil (SR-25776) is a stimulant and nootropic drug which acts as a partial inverse agonist at benzodiazepine sites on the GABAA receptor. In human trials it was found to partially reverse the sedative and amnestic effects of the hypnotic drug triazolam with only slight effects when administered by itself.[1]
See also
References
- ↑ Warot D, Danjou P, Douillet P, Keane P, Puech AJ. Cognitive impairments induced by triazolam in healthy volunteers: antagonism by a partial inverse agonist of benzodiazepine receptor. Therapie. 1994 Jan-Feb;49(1):23-6. PMID 8091361
This article is issued from Wikipedia - version of the 9/1/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.